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A great number of chemical modifications to the structure of rifamycins have been made, especially at 3 or 4 position of naphthoquinone or naphthohydroquinone chromophore. Any modification in the ansa bridge generally reduces the activity. From all the chemical and physical studies done on rifamycins, it has been concluded that the structural features necessary for the activity are: 1) presence of a naphthalene ring carrying oxygen atoms at C(1) and C(8) either in the quinone or hydroquinone form, 2) hydroxyl groups at position C(21) and C(23) of ansa chain, and 3) a well-defined spatial arrangement of oxygen atoms at C(21) and C(23).
X-Ray structural studies on both active (rifampicin4), rifamycin B5), rifamycin SV6), and 3-carbomethoxyrifamycin SV7) and inactive (tolypomycinone8), rifamycin S iminomethyl ether9)) rifamycins have been carried out recently to correlate the structure and activity in ansamycins. LANCINI and ZANCHELLI10) have published an excellent review on structure-activity relationships in ansamycins. The present study presents the first X-ray investigation of a cyclized rifamycin ( Fig. 1 ) and this reveals changes in the conformation of ansa chain due to cyclization.
The cyclized rifamycin SV was kindly provided by Dr. J. R. MCCARTHY of DuPont. Needleshaped crystals were obtained from aqueous methanol. A crystal measuring 0.1 x 0.2 x 0.3 mm was used for the measurement of cell constants and data collection. The crystal data: C38H46-NO11i monoclinic P21, a=20.347(7), b=7.978(2), c=23.364 (7) A, 3=100.6°, Z=4 (two molecules/ asymmetric unit), Dc=1.233 g/cm3. The intensities of 5720 reflections with 20> 105 were measured using CuKa radiation (A1=1.54178 A on a Syntex P3/F diffractometer, using a 0-20 scan technique, a variable scan rate (0.5-29.3 minutes), a scan range of 2.0°, and a background to scan ratio of 0.8. 3923 reflections with I> 3a(I) were observed. The intensities were corrected for Lorentz and polarization effects.
Attempts to solve the structure (100 atoms/ asymmetric unit) by direct methods program MULTAN 7811) succeeded only in obtaining partial structure. Further attempts to develop this partial structure were unsuccessful even after applying the translation function. At this stage, attempts with the latest and more powerful version of direct methods program MULTAN 82 succeeded in revealing the complete structure. The initial R factor with all the 100 nonhydrogen atoms included was 0.291. Three cycles of isotropic least-squares refinement reduced R to 0.079. Attempts to locate H atoms in the difference Fourier map were only partially successful and so hydrogen atoms were not included in the refinement. The refinement was based on Fo, the quantity minimized being Z(Fo-Fc)2). The weighing scheme used was based on counter statistics as defined by CORFIELD et a1.12), the value of P being 0.04. The scattering factors used were those of HANSON et al. 13> The bond lengths and angles in the two molecules in the asymmetric unit agree reasonably well. The cyclization does not seem to affect the lengths of bonds that are involved in the cyclization, e.g. C(1)-C(2), C(2)-N, C(15)-N when compared to similar bonds in rifamycin SV.
The stereochemistry of the molecule is shown in Fig. 2 The spatial arrangement of the four atoms O(1), 0(2), 0(9) and 0(10), which is an important factor in the binding of the rifamycins to DDRP, is different in the present study than that found in rifampicin, rifamycin SV, and rifamycin B. This is expected because of the cyclization involving 0(1) and also having a methoxyl rather than a hydroxyl group at C (8) . The bonds C(21)-0(10) and C(23)-O(9) are pointed toward the planar part of the molecule rather than parallel to it. This is similar to that observed in inactive rifamycins. Fig. 3 shows the spatial requirement for the active and inactive rifamycins. Fig. 4 shows the comparison of the conformation of cyclized rifamycin SV molecule and rifamycin SV. There is vast difference in the conformation of ansa chain. Scanning through torsion angles along the ansa chain, one observes an interesting feature; i.e., in all the rifamycins that have activity against DDRP, (3-carbomethoxyrifamycin, rifamycin B, rifampicin, rifamycin SV), the torsion angle C(2l) 
